About Lewis Pannell
Dr. Lewis Pannell, who received his Ph.D. in Chemistry from the University of Canterbury, Christchurch, New Zealand, is head of the Proteomics and Mass Spectrometry Laboratory at the Mitchell Cancer Institute (MCI). Previously, Dr. Pannell served as senior investigator with the National Institutes of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD. His research team currently focuses on several areas of research including improving the early detection of late stage cancers such as pancreatic cancer, determining new biomarkers for gynecological cancers, developing new screening methods for non-cancer related issues such as pregnancy complications, and improving methods for the testing of prostate cancer.